References
- ZhangLChenQYLiuHTangLQMaiHQEmerging treatment options for nasopharyngeal carcinomaDrug Des Devel Ther201373752
- ChanATHsuMMGohBCMulticenter, Phase III study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinomaJ Clin Oncol200523153568357615809453
- LeeNYZhangQPfisterDGAddition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a Phase II multi-institutional trialLancet Oncol201213217218022178121
- ChuaDTWeiWIWongMPShamJSNichollsJAuGKPhase II study of gefitinib for the treatment of recurrent and metastatic nasopharyngeal carcinomaHead Neck200830786386718213730
- LeungTWTungSYSzeWKTreatment results of 1070 patients with nasopharyngeal carcinoma: an analysis of survival and failure patternsHead Neck200527755556515880410
- WakisakaNWenQHYoshizakiTAssociation of vascular endothelial growth factor expression with angiogenesis and lymph node metastasis in nasopharyngeal carcinomaLaryngoscope1999109581081410334236
- SunTXuJEffect of bevacizumab on apoptosis of drug-resistant nasopharyngeal carcinoma cellsMed J Chinese Peoples Liberat Army20083314381440
- ChuaDTShamJSWeiWIHoWKAuGKThe predictive value of the 1997 American Joint Committee on Cancer stage classification in determining failure patterns in nasopharyngeal carcinomaCancer200192112845285511753958
- DruzgalCHChenZYehNTA pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinomaHead Neck200527977178415920746
- FujitaKSanoDKimuraMAnti-tumor effects of bevacizumab in combination with paclitaxel on head and neck 6qlJlmUS cell carcinomaOncol Rep20071818475117549344
- ShaDHeYJWangWBHanJQAnti-nasopharyngeal carcinoma effect in vivo and in vitro of Avastin and adenovirus-thymidine kinase suicide geneZhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi2007427526532 Chinese17886683
- HuangGWMasanoriSLinJEThe relationship between microvessel density, the expression of vascular endothelial growth factor (VEGF), and the extension of nasopharyngeal carcinomaLaryngoscope2000110122066206911129022
- LuoRCKangSJExperimental and clinical research progress in biotherapy for nasopharyngealJ Oncol2008141821
- ZhangLHuangYQinTMulticenter, randomized, controlled, open-label study of bevacizumab combined with carboplatin and paclitaxel versus carboplatin and paclitaxel in patients with metastatic nasopharyngeal carcinomaJ Clin Oncol2014325s Suppl; abstr TPS6100